Environmental estrogens and obesity. Mol Cell Endocrinol

Developmental Endocrinology and Endocrine Disruptor Section, Laboratory of Molecular Toxicology, National Institute of Environmental Health Sciences, NIH, DHHS, Research Triangle Park, NC 27709, United States.
Molecular and Cellular Endocrinology (Impact Factor: 4.41). 06/2009; 304(1-2):84-9. DOI: 10.1016/j.mce.2009.02.024
Source: PubMed


Many chemicals in the environment, in particular those with estrogenic activity, can disrupt the programming of endocrine signaling pathways that are established during development and result in adverse consequences that may not be apparent until much later in life. Most recently, obesity and diabetes join the growing list of adverse consequences that have been associated with developmental exposure to environmental estrogens during critical stages of differentiation. These diseases are quickly becoming significant public health issues and are fast reaching epidemic proportions worldwide. In this review, we summarize the literature from experimental animal studies documenting an association of environmental estrogens and the development of obesity, and further describe an animal model of exposure to diethylstilbestrol (DES) that has proven useful in studying mechanisms involved in abnormal programming of various differentiating estrogen-target tissues. Other examples of environmental estrogens including the phytoestrogen genistein and the environmental contaminant Bisphenol A are also discussed. Together, these data suggest new targets (i.e., adipocyte differentiation and molecular mechanisms involved in weight homeostasis) for abnormal programming by estrogenic chemicals, and provide evidence that support the scientific hypothesis termed "the developmental origins of adult disease". The proposal of an association of environmental estrogens with obesity and diabetes expands the focus on the diseases from intervention/treatment to include prevention/avoidance of chemical modifiers especially during critical windows of development.

Download full-text


Available from: Wendy Jefferson, Jul 23, 2014
    • "As BPA exposure is near ubiquitous in developed countries and any negative health effects may be the result of exposure decades earlier, it is very difficult to build reliable epidemiological data. Cross-sectional studies comparing BPA exposure with current health effects have been conducted, with a minority of these showing a positive correlation (see Braun et al. 2009; Newbold et al. 2009; Melzer et al. 2010; Clayton et al. 2011; Li et al. 2011); however, these results are only preliminary. This difficulty also problematises regulatory evaluations. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This article aims to provide a broad overview of current debates around the safety of bisphenol A (BPA), a commonly used chemical in consumer products, and to argue for greater engagement by the New Zealand government and public with these debates. BPA acts as an endocrine disrupting chemical (EDC), a relatively new category of harmful chemicals that pose a challenge to conventional toxicological assessments. There are ongoing debates surrounding BPA's potential to have harmful effects on human health at current doses, and how to evaluate the reliability of conflicting studies. Based on this uncertainty, a number of countries have taken a precautionary approach and regulated BPA. The debate has also moved into the public arena, with strong public opposition to BPA in countries such as the United States of America. The New Zealand government has maintained its position that BPA is safe without fully considering the challenges it may pose as an EDC or additive effects with other EDCs. Based on a preliminary investigation, there does not currently appear to be a high level of public awareness or opposition to BPA in New Zealand. The authors argue that the New Zealand government and the public could benefit from engaging with current debates on BPA's safety.
    No preview · Article · Sep 2015 · Journal- Royal Society of New Zealand
  • Source
    • "Despite from these numerous beneficial reports there are also concerns that ISOs, similar to other estrogenic compounds , promote fat accumulation and therefore consumption may be associated with an increased risk to develop obesity [15] [16] [17]. These concerns are in part based on the evidence that during critical periods of development estrogenic chemicals can have stimulatory effects on the development of obesity [18]. Obesogenic mechanisms were already discussed for xenoestrogens like bisphenol A [19] and diethylstilbestrol [20]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Scope: Traditional Asian diet rich in soy isoflavones (ISOs) is discussed to be linked to a lower obesity prevalence. In lifelong and short-term exposure scenarios we investigated effects of an ISO-rich diet on the body composition and development of obesity in female rats. Methods and results: Female Wistar rats grew up on ISO-free or ISO-rich control diet (CON ISO: 467 mg/kg diet). Starting postnatal day 83, ovariectomized and intact animals received high calorie Western diet (WD) in the absence or presence of ISO (WD ISO: 431 mg/kg diet) for 12 weeks to induce obesity or maintained on respective CON. One group starting ISO exposure after ovariectomy mimics short-term ISO exposure in postmenopausal Western women. Lifelong but not short-term ISO exposure resulted in reduced body weight, visceral fat mass, serum leptin and smaller adipocytes. ISO decreased hepatic SREBP-1c, ACC, FAS and PPARγ mRNA expression in non-obese animals. Moreover, ovariectomy reduced skeletal muscle weight, which was antagonized by both short-term and lifelong ISO exposure. Conclusion: Our results indicate that in female rats lifelong but not short-term ISO intake reduces the risk to develop obesity. Furthermore, lifelong and short-term ISO exposure may antagonize loss of skeletal muscle mass induced by ovariectomy. This article is protected by copyright. All rights reserved.
    Full-text · Article · Sep 2015 · Molecular Nutrition & Food Research
    • "), complications with digestive and nutrient-assimilating processes and reproductive functions (Mendola et al. 2008; Newbold et al. 2009; Wigle et al. 2008) as well as cancer in animals and humans (Arlt et al. 2001; Weyer et al. 2001). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Sludge deposition in the environment is carried out in several countries. It encompasses the dispersion of treated or untreated sludge in forests, marsh lands, open waters as well as estuarine systems resulting in the gradual accumulation of toxins and persistent organic compounds in the environment. Studies on the life cycle of compounds from sludge deposition and the consequences of deposition are few. Most reports focus rather on treatment-methods and approaches, legislative aspects as well as analytical evaluations of the chemical profiles of sludge. This paper reviews recent as well as some older studies on sludge deposition in forests and other ecosystems. From the literature covered it can be concluded that sludge deposition induces two detrimental effects on the environment: (1) raising of the levels of persistent toxins in soil, vegetation and wild life and (2) slow and long-termed biodiversity-reduction through the fertilizing nutrient pollution operating on the vegetation. Since recent studies show that eutrophication of the environment is a major threat to global biodiversity supplying additional nutrients through sludge-based fertilization seems imprudent. Toxins that accumulate in the vegetation are transferred to feeding herbivores and their predators, resulting in a reduced long-term survival chance of exposed species. We briefly review current legislation for sludge deposition and suggest alternative routes to handling this difficult class of waste.
    No preview · Article · Aug 2015 · Ecotoxicology
Show more